DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Winblad B, Andreasen N, Minthon L. , et al.
Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study.
Lancet Neurol 2012;
11 (07) 597-604
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.